Co-Authors
This is a "connection" page, showing publications co-authored by Andrea Ciaranello and Rochelle Walensky.
Connection Strength
1.115
-
Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Jul; 6(7):ofz276.
Score: 0.207
-
HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing? Open Forum Infect Dis. 2018 Aug; 5(8):ofy170.
Score: 0.196
-
The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV. J Adolesc Health. 2018 01; 62(1):22-28.
Score: 0.187
-
The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis. PLoS Med. 2017 Nov; 14(11):e1002446.
Score: 0.186
-
Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med. 2011 May 20; 9:59.
Score: 0.118
-
Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator). Clin Infect Dis. 2021 12 16; 73(12):2248-2256.
Score: 0.062
-
Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa559.
Score: 0.057
-
Outcomes from an infectious disease physician-guided evaluation of hospitalized persons under investigation for coronavirus disease 2019 (COVID-19) at a large US academic medical center. Infect Control Hosp Epidemiol. 2021 03; 42(3):344-347.
Score: 0.056
-
Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017 10 15; 65(8):1266-1271.
Score: 0.046